SyntekaBio,Inc. Logo

SyntekaBio,Inc.

AI drug discovery platform accelerating R&D with supercomputing, SaaS, and pre-made candidates.

226330 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 국제과학17로 18 -, 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SyntekaBio is an AI-driven drug discovery company that utilizes its proprietary supercomputing infrastructure to accelerate the development of therapeutics. The company's core platform, DeepMatcher®, automates the process of identifying and optimizing drug candidates from hit screening to preclinical lead generation. SyntekaBio offers its technology through several business models: STB LaunchPad, a repository of pre-made, 'off-the-shelf' drug candidates for over 100 disease targets; end-to-end discovery and development services; and a suite of CLOUD-SaaS modules for specific applications like small molecule analysis (Sm-ARS), neoantigen prediction (NEO-ARS), and antibody design (Ab-ARS). This 'factory-like' approach aims to reduce the time and cost of pharmaceutical R&D for its partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.1 KB
2025-09-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.9 KB
2025-09-12 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 85.9 KB
2025-09-12 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-09-12 00:00
Capital/Financing Update
단기차입금감소결정(자율공시)
Korean 7.0 KB
2025-09-12 00:00
Major Shareholding Notification
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Korean 12.4 KB
2025-09-12 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 30.4 KB
2025-09-12 00:00
Registration Form
증권신고서(지분증권) (2025.12)
Korean 2.4 MB
2025-09-03 00:00
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
Korean 79.9 KB
2025-09-03 00:00
Capital/Financing Update
단기차입금증가결정
Korean 9.1 KB
2025-08-26 00:00
Capital/Financing Update
주요사항보고서(자기전환사채매도결정)
Korean 29.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 97.1 KB
2025-07-21 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 9.7 KB
2025-07-15 00:00
Regulatory News Service
본점소재지변경
Korean 5.0 KB

Automate Your Workflow. Get a real-time feed of all SyntekaBio,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SyntekaBio,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.